Urologic Research Research Articles

Implementation of a shared research database to increase medical student awareness and involvement in urology research A pilot study.

We aimed to assess the effect of a shared institutional research database on medical students' scholarly work, perceived research competency, and self-reported satisfaction. An institutional inventory database was created on Google Sheets with a listing of available mentors and a description of their ongoing research projects. The inventory database was shared with interested students and faculty. Students who agreed to participate were surveyed pre- and post-inventory. Survey questions assessed student demographics, prior research experience, and their perception of research competency and satisfaction. The number of presentations, publications, and articles pre- and post-inventory were also abstracted. Survey responses were compared using the Mann-Whitney U test. A total of 20 students were surveyed pre-inventory and at a median followup of six months (5-7) post-inventory. There was a significant increase in scholarly presentations and publications post-inventory (p<0.05 for all). Furthermore, post-inventory, students reported feeling more confident in establishing an academic career, finding good mentors, managing their relationship with their mentor, managing professional challenges, and effectively showcasing themselves professionally and describing their research (p<0.05 for all). More than 65% of students agreed or strongly agreed that the database was easy to use, accessible, transparent, and would like a similar database created for other specialty departments. After performing mentorship-guided research through an institutional research database, medical students felt more confident in their ability to perform research and produced more scholarly work. Therefore, we recommend a research database be created across all institutional departments to foster interest in conducting research.

Exploring the Ethical, Legal, and Social Implications of ChatGPT in Urology.

ChatGPT is programmed to generate responses based on pattern recognition. With this vast popularity and exponential growth, the question arises of moral issues, security and legitimacy. In this review article, we aim to analyze the ethical and legal implications of using ChatGPT in Urology and explore potential solutions addressing these concerns. There are many potential applications of ChatGPT in urology, and the extent to which it might improve healthcare may cause a profound shift in the way we deliver our services to patients and the overall healthcare system. This encompasses diagnosis and treatment planning, clinical workflow, patient education, augmenting consultations, and urological research. The ethical and legal considerations include patient autonomy and informed consent, privacy and confidentiality, bias and fairness, human oversight and accountability, trust and transparency, liability and malpractice, intellectual property rights, and regulatory framework. The application of ChatGPT in urology has shown great potential to improve patient care and assist urologists in various aspects of clinical practice, research, and education. Complying with data security and privacy regulations, and ensuring human oversight and accountability are some potential solutions to these legal and ethical concerns. Overall, the benefits and risks of using ChatGPT in urology must be weighed carefully, and a cautious approach must be taken to ensure that its use aligns with human values and advances patient care ethically and responsibly.

Association Between Common Urologic Medications and Onset of Alzheimer’s Disease and Related Dementias in Men With Prostate Cancer Managed by Different Primary Treatment Modalities

To understand the relationship between common urologic medications phosphodiesterase-5 inhibitors (PDE5i) and anticholinergics (AC) and risk of dementia onset in men who underwent different primary treatments for prostate cancer. Patients (>50years) with prostate cancer (1998-2022) without Alzheimer's disease or related dementias were selected from Cancer of the Prostatic Strategic Urologic Research Endeavor Registry. Minimum medication use was 3months. Fine-Gray regression was performed to determine the association between medication exposure and dementia onset ≥12months after primary treatment in men matched on age, race, comorbid conditions, smoking, and type of clinical site, with competing risk of death. Among 5937 men (53% PDE5i; 14% AC), PDE5i users were younger (63 vs 70, P<.01) with less CAD, CVA, DM (all P<.01); AC users were older (68 vs 66, P<.01) with higher incidence of comorbidities (P<.01). Median months of use was 24.3 (IQR 12.1, 48.7) for PDE5i and 12.2 (IQR 6.1, 24.3) for AC users. Cumulative incidence of Alzheimer's disease or related dementias was 6.5% at 15years. PDE5i (P=.07) and AC (P=.06) were not associated with dementia regardless of primary treatment modality. In this retrospective cohort study, PDE5i and AC use do not appear independently associated with risk of dementia. Notably, our cohort was generally healthy and younger which may limit our ability to detect significance. We recommend prospective investigation into association between PDE5i and dementia and advise continued judicious stewardship of AC in older patient populations.

Bridging the Gap Between Urological Research and Patient Understanding: The Role of Large Language Models in Automated Generation of Layperson's Summaries.

This study assessed ChatGPT's ability to generate readable, accurate, and clear layperson summaries of urological studies, and compared the performance of ChatGPT-generated summaries with original abstracts and author-written patient summaries to determine its effectiveness as a potential solution for creating accessible medical literature for the public. Articles from the top 5 ranked urology journals were selected. A ChatGPT prompt was developed following guidelines to maximize readability, accuracy, and clarity, minimizing variability. Readability scores and grade-level indicators were calculated for the ChatGPT summaries, original abstracts, and patient summaries. Two MD physicians independently rated the accuracy and clarity of the ChatGPT-generated layperson summaries. Statistical analyses were conducted to compare readability scores. Cohen's κ coefficient was used to assess interrater reliability for correctness and clarity evaluations. A total of 256 journal articles were included. The ChatGPT-generated summaries were created with an average time of 17.5 (SD 15.0) seconds. The readability scores of the ChatGPT-generated summaries were significantly better than the original abstracts, with Global Readability Score 54.8 (12.3) vs 29.8 (18.5), Flesch Kincade Reading Ease 54.8 (12.3) vs 29.8 (18.5), Flesch Kincaid Grade Level 10.4 (2.2) vs 13.5 (4.0), Gunning Fog Score 12.9 (2.6) vs 16.6 (4.1), Smog Index 9.1 (2.0) vs 12.0 (3.0), Coleman Liau Index 12.9 (2.1) vs 14.9 (3.7), and Automated Readability Index 11.1 (2.5) vs 12.0 (5.7; P < .0001 for all except Automated Readability Index, which was P = .037). The correctness rate of ChatGPT outputs was >85% across all categories assessed, with interrater agreement (Cohen's κ) between 2 independent physician reviewers ranging from 0.76-0.95. ChatGPT can create accurate summaries of scientific abstracts for patients, with well-crafted prompts enhancing user-friendliness. Although the summaries are satisfactory, expert verification is necessary for improved accuracy.

Experimental Animal Models for Preclinical Investigation of the Bladder Cancer

Abstract: The current treatments for bladder cancer are unable to substantially avoid the disease's growth and recurrence, which is a serious public health problem. Researchers have explored a variety of approaches in an effort to effectively replicate the pathophysiology of human tumors using experimental tumor models. The investigation of the available models is a necessary tool in order to choose the most appropriate scheme which serves the translation of potential treatments from a primary experimental bench to the clinical settings. The most suitable murine models of bladder cancer should have excellent reproductivity, intravesical predictability, and accessibility in order to facilitate the mechanistic, chemopreventive, and therapeutic research that can be expanded into clinical trials. This article provides a complete evaluation of both in vitro and in vivo bladder cancer models, comparing their advantages and limitations in urological research.

Guidelines for Reporting Observational Research in Urology: The Importance of Clear Reference to Causality.

Guidelines for Reporting Observational Research in Urology: The Importance of Clear Reference to Causality.

Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancer

BackgroundTo report objective long-term complications and health related quality of life (HRQOL) outcomes after radical prostatectomy (RP) with and without radiation therapy (RT) for prostate cancer (CaP). MethodsWe analyzed patients diagnosed with CaP who underwent RP from the UCSF Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) registry between 1995 and 2020. Cox proportional hazards were used to assess risk of postoperative complications which included cystitis, gastrointestinal (GI) toxicity, incontinence requiring a surgical procedure, ureteral injury and urinary stricture. Repeated measures mixed models were used to assess the effects of radiation and complications on patient-reported urinary, bowel, and sexual function after surgery. ResultsOf 6,258 men who underwent RP, cumulative incidence of EBRT was 9.1% at 5 years after surgery. Patients who received postoperative radiation were at increased risk for onset of cystitis (HR 5.60, 95% CI 3.40–9.22, P < 0.01). Receipt of RT was not associated with other complications. In repeated measures analysis, postoperative RT was associated with worsening general health scores, adjusting for complications of incontinence, urinary stricture, GI toxicity or ureteral injury, independent of whether patients had those complications. ConclusionsRT after RP was associated with an increase in the risk of cystitis and worse general health in the long term. Other complications and HRQOL outcomes did not demonstrate differences by whether patients had RT or not. While post-operative RT is the only curative option for CaP after RP, patients and providers should be aware of the increased risks when making treatment decisions.

The Journal of Urology® Home Study Course 2023 Volume 209/210.

The Journal of Urology® Home Study Course 2023 Volume 209/210.

MP47-13 A Comparative Analysis of Robot-assisted Retroperitoneoscopic Partial Nephrectomy (RARPN) for Anterior vs Posterior Renal Tumors: A Propensity Score Matched Analysis in a Multi-institutional Cohort.

You have accessJournal of UrologyErrata1 Jul 2023MP47-13 A Comparative Analysis of Robot-assisted Retroperitoneoscopic Partial Nephrectomy (RARPN) for Anterior vs Posterior Renal Tumors: A Propensity Score Matched Analysis in a Multi-institutional Cohortis correction ofMP47-13 A COMPARATIVE ANALYSIS OF ROBOT-ASSISTED RETROPERITONEOSCOPIC PARTIAL NEPHRECTOMY (RARPN) FOR ANTERIOR VS POSTERIOR RENAL TUMORS: A PROPENSITY SCORE MATCHED ANALYSIS IN A MULTI-INSTITUTIONAL COHORT View All Author Informationhttps://doi.org/10.1097/JU.0000000000003489AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail Volume 209, Issue Supplement 4, Page e649: The fourth author’s name is Mukund Bhandari and the fifth author's name is Indu Saini. The online and PDF versions of the article have been updated. © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology23 Mar 2023MP47-13 A COMPARATIVE ANALYSIS OF ROBOT-ASSISTED RETROPERITONEOSCOPIC PARTIAL NEPHRECTOMY (RARPN) FOR ANTERIOR VS POSTERIOR RENAL TUMORS: A PROPENSITY SCORE MATCHED ANALYSIS IN A MULTI-INSTITUTIONAL COHORT Volume 210Issue 1July 2023Page: 222-222 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Expand All Advertisement Advertisement PDF downloadLoading ...

Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma.

No AccessJournal of UrologyErrata1 Jul 2023Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinomais correction ofEfficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma View All Author Informationhttps://doi.org/10.1097/JU.0000000000003500AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma." The Journal of Urology, 210(1), p. 223 © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology19 Jan 2023Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma Volume 210Issue 1July 2023Page: 223-223 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Expand All Advertisement PDF downloadLoading ...

MP28-14 Real-World Survival Outcomes Associated With Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Papillary Renal Cell Carcinoma

You have accessJournal of UrologyErrata1 Jul 2023MP28-14 Real-World Survival Outcomes Associated With Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Papillary Renal Cell Carcinomais correction ofMP28-14 REAL-WORLD SURVIVAL OUTCOMES ASSOCIATED WITH IMMUNOTHERAPY, TARGETED THERAPY, AND COMBINATION THERAPY FOR METASTATIC PAPILLARY RENAL CELL CARCINOMA View All Author Informationhttps://doi.org/10.1097/JU.0000000000003517AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail Volume 209, Supplement 4, Page e376: The eighth through 14th authors’ names are Monica Morgan, Brian J. Miles, Taliah Muhammad, Maryam Anis, Monty Aghazadeh, Jun Zhang, and Eleni Efstathiou, and the 17th author’s name is Brian Rini. The online and PDF versions of the article have been updated. © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology23 Mar 2023MP28-14 REAL-WORLD SURVIVAL OUTCOMES ASSOCIATED WITH IMMUNOTHERAPY, TARGETED THERAPY, AND COMBINATION THERAPY FOR METASTATIC PAPILLARY RENAL CELL CARCINOMA Volume 210Issue 1July 2023Page: 224-224 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Expand All Advertisement Advertisement PDF downloadLoading ...

Editorial Comment

No AccessJournal of UrologyNew Technology and Techniques1 Jul 2023Editorial CommentThis article comments on the following:A Prospective Multi-institutional Study Using a Novel Safety Valve for the Prevention of Catheter Balloon Inflation Injury of the Urethrais a letter which has replyReply by Authors Nathan Lawrentschuk Nathan LawrentschukNathan Lawrentschuk EJ Whitten Prostate Cancer Centre, Epworth Healthcare, University of Melbourne, Melbourne, Australia Department of Surgery, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003449.01AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Editorial Comment." The Journal of Urology, 210(1), p. 185 REFERENCES 1. A prospective multi-institutional study using a novel safety valve for the prevention of catheter balloon inflation injury of the urethra. J Urol. 2023; 210(1):179-185. Link, Google Scholar 2. Sensible government decisions on funding for imaging can change practice and deliver better care for men with prostate cancer. BJU Int. 2022; 130(Suppl 1):4. Google Scholar 3. There is a need for a universal language in the reporting and grading of complication and intervention events to ensure comparability and improvement of surgical care. Eur Urol. 2022; 81(5):440-445. Crossref, Medline, Google Scholar 4. Evolution and implications of the novel CAMUS reporting and classification system: from rationale to end product. Eur Urol Open Sci. 2023; 50:123-126. Crossref, Medline, Google Scholar © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology31 Mar 2023A Prospective Multi-institutional Study Using a Novel Safety Valve for the Prevention of Catheter Balloon Inflation Injury of the UrethraJournal of Urology9 Jun 2023Reply by Authors Volume 210Issue 1July 2023Page: 185-185 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Nathan Lawrentschuk EJ Whitten Prostate Cancer Centre, Epworth Healthcare, University of Melbourne, Melbourne, Australia Department of Surgery, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia More articles by this author Expand All Advertisement PDF downloadLoading ...

First in Human Subjects Testing of the UroMonitor: A Catheter-free Wireless Ambulatory Bladder Pressure Monitor.

Urodynamics is the standard method of diagnosing bladder dysfunction, but involves catheters and retrograde bladder filling. With these artificial conditions, urodynamics cannot always reproduce patient complaints. We have developed a wireless, catheter-free intravesical pressure sensor, the UroMonitor, which enables catheter-free telemetric ambulatory bladder monitoring. The purpose of this study was twofold: to evaluate accuracy of UroMonitor pressure data, and assess safety and feasibility of use in humans. Eleven adult female patients undergoing urodynamics for overactive bladder symptoms were enrolled. After baseline urodynamics, the UroMonitor was transurethrally inserted into the bladder and position was confirmed cystoscopically. A second urodynamics was then performed with the UroMonitor simultaneously transmitting bladder pressure. Following removal of urodynamics catheters, the UroMonitor transmitted bladder pressure during ambulation and voiding in private. Visual analogue pain scales (0-5) were used to assess patient discomfort. The UroMonitor did not significantly alter capacity, sensation, or flow during urodynamics. The UroMonitor was also easily inserted and removed in all subjects. The UroMonitor reproduced bladder pressure, capturing 98% (85/87) of voiding and nonvoiding urodynamic events. All subjects voided with only the UroMonitor in place with low post-void residual volume. Median ambulatory pain score with the UroMonitor was rated 0 (0-2). There were no post-procedural infections or changes to voiding behavior. The UroMonitor is the first device to enable catheter-free telemetric ambulatory bladder pressure monitoring in humans. The UroMonitor appears safe and well tolerated, does not impede lower urinary tract function, and can reliably identify bladder events compared to urodynamics.

This Month in Pediatric Urology.

No AccessJournal of UrologyThis Month in Pediatric Urology22 Jun 2023This Month in Pediatric Urology Julian Wan Julian WanJulian Wan More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003595AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail "This Month in Pediatric Urology." The Journal of Urology, Publish Ahead of Print, pp. REFERENCES 1. . On Social Structure and Science. University of Chicago Press; 1996. Google Scholar 2. . “I just haven't done any of that”: applicability of the International Index of Erectile Function in young men with spina bifida. J Urol.2023; 210(3):000-000. Google Scholar © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Julian Wan More articles by this author Expand All Advertisement PDF downloadLoading ...

Editorial Comment.

No AccessJournal of UrologyAdult Urology21 Jun 2023Editorial CommentThis article comments on the following:Biopsy Assessment of Oncologic Control 3 Years Following Primary Partial Gland Cryoablation: A Prospective Cohort Study of Men With Intermediate-risk Prostate Cancer Taimur T. Shah Taimur T. ShahTaimur T. Shah Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, United Kingdom Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003569.01AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail "Editorial Comment." The Journal of Urology, Publish Ahead of Print, pp. REFERENCES 1. . Biopsy assessment of oncologic control three years following primary partial gland cryoablation: a prospective cohort study of men with intermediate risk prostate cancer. J Urol. 2023; 210(3):000-000. Google Scholar 2. Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2023; 388(17):1547-1558. Crossref, Medline, Google Scholar 3. PACE-A: an international phase 3 randomised controlled trial (RCT) comparing stereotactic body radiotherapy (SBRT) to surgery for localised prostate cancer (LPCa)—primary endpoint analysis. J Clin Oncol. 2023; 41(6_suppl):298. Crossref, Google Scholar 4. . MP80-16 Black patients have worse continence outcomes at 12 months following robotic-assisted radical prostatectomy. J Urol. 2023; 209(suppl 4):e1159. Abstract, Google Scholar 5. Early-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry. Eur Urol. 2019; 76(1):98-105. Crossref, Medline, Google Scholar 6. Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study. Prostate Cancer Prostatic Dis. 2021; 24(2):567-574. Crossref, Medline, Google Scholar © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology7 Jun 2023Biopsy Assessment of Oncologic Control 3 Years Following Primary Partial Gland Cryoablation: A Prospective Cohort Study of Men With Intermediate-risk Prostate Cancer Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Taimur T. Shah Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, United Kingdom Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom More articles by this author Expand All Advertisement PDF downloadLoading ...

Editorial Comment.

No AccessJournal of UrologyAdult Urology21 Jun 2023Editorial CommentThis article comments on the following:Randomized Controlled Trial of Single-dose Perioperative Pregabalin in Ureteroscopy Anna Ricapito, Raymond Khargi, and Alan J. Yaghoubian Anna RicapitoAnna Ricapito Department of Urology and Kidney Transplant, University of Foggia, Foggia, Italy More articles by this author , Raymond KhargiRaymond Khargi Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York More articles by this author , and Alan J. YaghoubianAlan J. Yaghoubian Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003572.02AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail "Editorial Comment." The Journal of Urology, Publish Ahead of Print, pp. REFERENCES 1. Randomized controlled trial of single-dose perioperative pregabalin in ureteroscopy. J Urol. 2023; 210(3). Google Scholar 2. Immediate and controlled-release pregabalin for the treatment of epilepsy. Expert Rev Neurother. 2019; 19(12):1167-1177. Crossref, Medline, Google Scholar 3. Risk factors for increased stent-associated symptoms following ureteroscopy for urinary stones: results from STENTS. J Urol. 2023; 209(5):971-980. Link, Google Scholar © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology12 Jun 2023Randomized Controlled Trial of Single-dose Perioperative Pregabalin in Ureteroscopy Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Anna Ricapito Department of Urology and Kidney Transplant, University of Foggia, Foggia, Italy More articles by this author Raymond Khargi Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York More articles by this author Alan J. Yaghoubian Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York More articles by this author Expand All Advertisement PDF downloadLoading ...

Infection and Inflammation of the Genitourinary Tract.

No AccessJournal of UrologyUrological Survey21 Jun 2023Infection and Inflammation of the Genitourinary Tract J. Quentin ClemensMD, FACS, MSCI J. Quentin ClemensJ. Quentin Clemens More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003596AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail "Infection and Inflammation of the Genitourinary Tract." The Journal of Urology, Publish Ahead of Print, pp. © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information J. Quentin Clemens More articles by this author Expand All Advertisement PDF downloadLoading ...

Editorial Comment.

No AccessJournal of UrologyAdult Urology21 Jun 2023Editorial CommentThis article comments on the following:Randomized Controlled Trial of Single-dose Perioperative Pregabalin in Ureteroscopy John Michael DiBianco and Chase Mallory John Michael DiBiancoJohn Michael DiBianco Department of Urology, University of Florida, Gainesville, Florida More articles by this author and Chase MalloryChase Mallory Department of Urology, University of Florida, Gainesville, Florida More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003572.04AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail "Editorial Comment." The Journal of Urology, Publish Ahead of Print, pp. REFERENCES 1. . Trends in the setting and cost of ambulatory urological surgery: an analysis of 5 states in the healthcare cost and utilization project. Urol Pract. 2019; 6(2):79-85. Link, Google Scholar 2. A prospective randomized study evaluating the necessity of narcotics following ureteroscopy for urinary stone disease. World J Urol. 2022; 40(10):2567-2573. Crossref, Medline, Google Scholar 3. Randomized controlled trial of single-dose perioperative pregabalin in ureteroscopy. J Urol. 2023; 210(3). Google Scholar 4. Enhanced recovery after surgery protocol for patients undergoing ureteroscopy: prospective evaluation of an opioid-free protocol. J Endourol. 2020; 34(6):647-653. Crossref, Medline, Google Scholar © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology12 Jun 2023Randomized Controlled Trial of Single-dose Perioperative Pregabalin in Ureteroscopy Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information John Michael DiBianco Department of Urology, University of Florida, Gainesville, Florida More articles by this author Chase Mallory Department of Urology, University of Florida, Gainesville, Florida More articles by this author Expand All Advertisement PDF downloadLoading ...

Editorial Comment.

No AccessJournal of UrologyAdult Urology21 Jun 2023Editorial CommentThis article comments on the following:Randomized Controlled Trial of Single-dose Perioperative Pregabalin in Ureteroscopy Naveen Kachroo Naveen KachrooNaveen Kachroo Vattikuti Urology Institute, Henry Ford Health, Detroit, Michigan Michigan State University, East Lansing, Michigan More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003572.01AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail "Editorial Comment." The Journal of Urology, Publish Ahead of Print, pp. REFERENCES 1. Randomized controlled trial of single-dose perioperative pregabalin in ureteroscopy. J Urol. 2023; 210(3). Google Scholar 2. Quality of life impact and recovery after ureteroscopy and stent insertion: insights from daily surveys in STENTS. BMC Urol. 2022; 22(1):53. Crossref, Medline, Google Scholar 3. Enhanced recovery after surgery protocol for patients undergoing ureteroscopy: prospective evaluation of an opioid-free protocol. J Endourol. 2020; 34(6):647-653. Crossref, Medline, Google Scholar 4. Impact of an enhanced recovery after surgery protocol on unplanned patient encounters in the early postoperative period after ureteroscopy. J Endourol. 2022; 36(3):298-302. Crossref, Medline, Google Scholar 5. SKOPE—study of ketorolac vs opioid for pain after endoscopy: a double-blinded randomized control trial in patients undergoing ureteroscopy. J Urol. 2021; 206(2):373-381. Link, Google Scholar © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology12 Jun 2023Randomized Controlled Trial of Single-dose Perioperative Pregabalin in Ureteroscopy Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Naveen Kachroo Vattikuti Urology Institute, Henry Ford Health, Detroit, Michigan Michigan State University, East Lansing, Michigan More articles by this author Expand All Advertisement PDF downloadLoading ...

Clinical Patient Summaries Not Fit for Purpose: A Study in Urology

We evaluated the comprehensibility of patient summaries provided by urology journals for the general public. The WebFX online tool was used to assess the readability of abstracts and patient summaries by scoring the text according to established readability indices. A total of 266 articles were included and statistical analysis was performed to compare the readability of abstracts and patient summaries, stratified by article type and text type. The results show that patient summaries consistently performed worse than abstracts for all readability metrics, and the readability levels for both abstracts and patient summaries were more advanced than the recommended guidelines on average. This study suggests that patient summaries provided by these urology journals may not be easily understood by the general population, and tools should be developed to help urological researchers improve the accessibility of their work. Patient summaryWe checked how easy it is to read and understand patient summaries and abstracts of research articles from four urology journals. We found that the summaries and abstracts were too hard to read. This study shows that we need to make these summaries easier to read for everyone.